Department Of Nuclear Medicine At Universit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Department of nuclear medicine at universit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Department Of Nuclear Medicine At Universit Today - Breaking & Trending Today

Radiopharm Theranostics Ltd taps nuclear medicine physician Dr Ken Herrmann for its scientific advisory board

Radiopharm Theranostics Ltd taps nuclear medicine physician Dr Ken Herrmann for its scientific advisory board
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Sara Hurvitz , David Ulmert , Eric Aboagye , Johannes Notni , David Mozley , Riccardo Canevari , Ken Herrmann , Radiopharm Theranostic , Susann Brady Kalnay , Department Of Nuclear Medicine At Universit , Radiopharm Theranostics Ltd , Nuclear Medicine , Professor Eric Aboagye , Professor David ,

Theragnostics Strengthens Board of Directors with Key Appointments

Theragnostics Strengthens Board of Directors with Key Appointments
Drug Development Experts Dr Dennis Langer and Professor Ken Herrmann Appointed as Non-Executive Directors
LONDON, Aug. 4, 2021 /PRNewswire/ Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, announces today the appointments of Dr Dennis Langer and Professor Ken Herrmann as Non-Executive Directors to its Board.
Dr Dennis Langer has served as a director of both public and private biotechnology, pharmaceutical and diagnostic companies, and has an extensive pharmaceutical company background. He previously served as CEO of Neose Technologies, Inc.; was President of Dr Reddy s North American business; and was Senior Vice President of Research and Development at GlaxoSmithKline plc. He is currently a Director of the Whitehead Institute for Biomedical Research, Myriad Genetics, Inc. (NASDAQ: MYGN) and Brooklyn ImmunoTherapeutics, Inc. (NYSE American: ....

United States , City Of , United Kingdom , Ian Gowrie Smith , Prnewswire Theragnostics , Dennis Langer , Greg Mullen , Drug Development Experts Dr Dennis Langer , University Of California Los Angeles , Harvard Law School , Whitehead Institute For Biomedical Research , Brooklyn Immunotherapeutics Inc , Columbia University , Genetics Inc , Georgetown University School Of Medicine , Department Of Nuclear Medicine At Universit , Department Of Nuclear Medicine , Neose Technologies Inc , Professor Ken Herrmann Appointed , Professor Ken Herrmann , Non Executive Directors , Neose Technologies , North American , Senior Vice President , Whitehead Institute , Biomedical Research ,